KLF4 and atherosclerosis: In this study, we demonstrated that ANGPTL4 administration significantly reduced atherosclerotic lesion size, macrophage content, vascular inflammation, and phenotypic transition of smooth muscle cells, contributing to plaque stabilization by downregulating NADPH oxidase 1 (NOX1) activation of KLF4 in an atherosclerosis mouse model.